152 results
Page 5 of 8
8-K
EX-99.1
te0nxmt2 amfd4zfvgfh
6 Nov 19
TherapeuticsMD Announces Third Quarter 2019 Financial Results
4:08pm
424B2
72ndv50tn 2v13vz43r
25 Oct 19
Prospectus for primary offering
4:47pm
FWP
5hhrq0
24 Oct 19
Free writing prospectus
6:02am
8-K
EX-99.1
nkixlu9 apy8ret
23 Oct 19
TherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results
5:25pm
FWP
jp9fl9x 3gwzrk
23 Oct 19
Free writing prospectus
5:16pm
424B5
za918n2
23 Oct 19
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
5so01mjz bu9qjzja
1 Oct 19
1 Investor Presentation October 2019 Building a Premier Women’s Health Portfolio
7:01am
8-K
EX-99.1
611z c3mjis7q
25 Sep 19
Regulation FD Disclosure
6:31am
8-K
EX-99.1
znzux9b2ocuf
16 Sep 19
1 Investor Presentation September 2019 Building a Premier Women’s Health Portfolio
6:46am
8-K
EX-99.1
hwa0tjao5t1bcd2my
6 Aug 19
TherapeuticsMD Announces Second Quarter 2019 Financial Results
4:07pm
8-K
EX-99.1
udh5zym6tk
9 Jul 19
Regulation FD Disclosure
6:57am
8-K
EX-99.1
8aymqm 07
10 Jun 19
Regulation FD Disclosure
2:28pm
8-K
EX-99.1
mq0qbr7k67n6 pmb
7 Jun 19
TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States
7:15am
8-K
EX-99.1
5l45mijqc2iv6pnlk5
6 May 19
TherapeuticsMD Announces First Quarter 2019 Financial Results
4:07pm
8-K
EX-99.1
q2glwwr4xyu
25 Apr 19
TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility
4:33pm